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New Zealand; and {University Computing Laboratory, University of Oxford, Oxford, United KingdomABSTRACT We present a metabolically regulated model of cardiac active force generation with which we investigate the
effects of ischemia on maximum force production. Our model, based on a model of cross-bridge kinetics that was developed
by others, reproduces many of the observed effects of MgATP, MgADP, Pi, and Hþ on force development while retaining the
force/length/Ca2þ properties of the original model. We introduce three new parameters to account for the competitive binding
of Hþ to the Ca2þ binding site on troponin C and the binding of MgADP within the cross-bridge cycle. These parameters, along
with the Pi and Hþ regulatory steps within the cross-bridge cycle, were constrained using data from the literature and validated
using a range of metabolic and sinusoidal length perturbation protocols. The placement of the MgADP binding step between two
strongly-bound and force-generating states leads to the emergence of an unexpected effect on the force-MgADP curve, where
the trend of the relationship (positive or negative) depends on the concentrations of the other metabolites and [Hþ]. The model is
used to investigate the sensitivity of maximum force production to changes in metabolite concentrations during the development
of ischemia.INTRODUCTIONFor the heart to fulfill its function as a pump, its musculature
must cyclically develop force, shorten, and relax. This cycle
is achieved by the expenditure of metabolic energy via path-
ways, the end-products of which are inhibitory to the cycle.
Such inhibition becomes particularly crucial during periods
of hypoxia or ischemia when the reduction in supply of
adenosine triphosphate (ATP) from mitochondrial oxidative
phosphorylation, and the attendant accumulation of inorganic
phosphate (Pi), adenosine diphosphate (ADP), and protons
may interfere with the cyclic interactions between actinmono-
mers andmyosinheads protruding from the thickfilaments (1).
Our aim is to develop a thermodynamically consistent and
metabolite-sensitive model of cardiac cross-bridge cycling to
explore the influence of these metabolites on force production
under physiological and ischemic conditions. There are
a number of criteria that such a model must meet. The cycling
action of cross-bridges is driven by the free energy released
from the hydrolysis of ATP into ADP and Pi (i.e., free energy
transduction). Firstly, therefore, the model must incorporate
a free energy-transducing thermodynamic cycle, with path-
ways that allow it to be driven in both forward and backward
directions (2). This excludes fading-memory models that
do not explicitly represent the cross-bridge cycle (3,4).
Secondly, the model must be thermodynamically consistent
as defined byHill (5), where a constraint is introduced to relate
the rate constants of the model to the free energy of ATP
hydrolysis. Thirdly, the model must explicitly incorporate
the regulatory effects of MgATP and its hydrolysis products,
MgADP, Pi, and Hþ. Sliding-filament models, derived fromSubmitted June 17, 2009, and accepted for publication October 8, 2009.
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0006-3495/10/01/0267/10 $2.00the seminal work ofHuxley (6), are based on strain-dependent
distributions of cross-bridge populations, and have been
extended to include metabolite interactions (7). However,
the explicit representation of a spatial dimension (cross-
bridge strain) requires the solution of partial differential
equations (PDEs), which renders them computationally
expensive and not ideal for integrating into cell or tissue
models. More recently, mean-field models have been
proposed that ignore the microscopic details of cross-bridge
population distributions and, instead, ascribe the behavior
of the entire cross-bridge population to an average cross-
bridge cycle, removing the need for PDEs.
In this study, we extend the recent mean-field model by
Rice et al. (8) such that it conforms to the criteria listed
above. The Rice et al. (8) model describes Ca2þ activation
and cross-bridge cycling kinetics and can reproduce a range
of myofilament behavior including length- and temperature-
dependent effects. This model provides a foundation onto
which a biochemical scheme of ATP hydrolysis is integrated
to develop a thermodynamically consistent and metabolite-
sensitive model of cross-bridge cycling kinetics (which we
denote as the Extended Model). The Extended Model intro-
duces three new parameters that are fitted using cardiac data
from the literature and validated against a range of metabolic
and sinusoidal length change protocols. The model is then
used to investigate the effects of changing metabolite
concentrations, observed after the onset of ischemia, on the
development of active force.METHODS
A schematic of the four-state model by Rice et al. (8) is shown in Fig. 1 A.
Rice et al. parameterized their model for rat cardiac tissue, and includedoi: 10.1016/j.bpj.2009.10.011
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FIGURE 1 (A) Original model from Rice et al. (8). (B) The original model is modified to include metabolite dependence (i.e., Extended Model). AM1 and
AM2 are two strongly-bound rapid-equilibrium states (dotted ellipse). The rate constants g0appT, g0xbT, and h0bT are true first-order rate constants that are inde-
pendent of metabolite concentrations whereas gappT, gxbT, and hbT from the original model are pseudo-first-order rate constants that are assumed to be implicit
functions of MgATP, MgADP, Pi, and Hþ (see text for details.) (C) Schematic of the competitive binding of Hþ to the Ca2þ binding site on troponin C. TRPN
and H-TRPN are assumed to be in rapid-equilibrium (dotted rectangle). The on-rate for Ca2þ binding, k0onT, is modified to include the H
þ regulation.
268 Tran et al.a parameter xbmodspecies (which multiplies all rate constants) to adjust to
different species. Consistent with our previous studies (9–11), we develop
a model parameterized for guinea pig myocardium, setting xbmodspecies ¼
0.2, effectively slowing the kinetics by fivefold from rat, following the find-
ings of Palmer and Kentish (12). We parameterize and validate against
guinea pig data where possible.
The original model implicitly assumes that cross-bridge cycling is irre-
versible by omitting a reverse step between states PXB and XBpostR. To
account for the full (reversible) thermodynamic cycle we add a reverse tran-
sition step, fxbT (Fig. 1 B), to allow transitions from state P back to state
XBpostR, representing the release of MgATP as the myosin-head transitions
from a weakly attached state back to a strongly attached state. The value of
fxbT is determined by the thermodynamic constraint that links the rate
constants in the cycle to the hydrolysis of MgATP (5),Q
ai
þQ
ai
¼ eDGATPRT ; (1)
where ai
þ and ai
– are the pseudo first-order forward and backward rate
constants for state i and
DGATP ¼ DG0ATP þ RTln
½MgADP½PiHþ 
½MgATP ; (2)
where DG0ATP is the standard free energy of MgATP hydrolysis and H
þ is
the proton released during ATP hydrolysis, which we label the metabolic
proton. (The equation for fxbT is given in the Appendix.)
Metabolite dependencies are incorporated into the transition rates between
steps of the cycle usingmass-actionkinetics.Wewill assume that normal phys-
iological metabolic conditions are given by MgATP ¼ 5 mM, MgADP ¼
36 mM, Pi ¼ 2 mM, and pH ¼ 7.15, and that the parameters and outputs
from Rice et al. (8) correspond to these conditions.
MgATP
The binding of MgATP in striated muscle detaches the cross-bridge from the
strongly-bound state after execution of the power stroke (13–16). Measure-
ments of isometric force have shown a descending trend with increasing
concentrations of MgATP, consistent with the dissociation of strongly-
bound cross-bridges (17,18). In the Extended Model (Fig. 1 B), the MgATP
binding step is therefore placed in the transition from state XBPostR to state
PXB (gxbT), during which the strongly-bound cross-bridge becomes
detached. It is also assumed that hydrolysis of ATP occurs at this step.
The Rice et al. (8) parameter for the transition, gxbT, is adjusted to account
for physiological MgATP concentrations using the formulationBiophysical Journal 98(2) 267–276g
0
xbT ¼
gxbT
MgATP
0 ; (3)
where g0xbT represents the true first-order rate constant, MgATP0 is the phys-
iological MgATP concentration, and gxbT is the pseudo-first order rate
constant from the Rice et al. (8) model. Following mass-action kinetics,
the MgATP-dependent transition rate from state XBPostR to state PXB is
therefore given by
g
0
xbT  ½MgATP: (4)
Under normal metabolic conditions, when [MgATP] ¼ MgATP0, this gives
g0xbT ¼ gxbT. This formulation is applied to the other metabolite dependen-
cies described below. The equation for this transition rate is not yet complete
as g0xbT is also modified by MgADP (see below).Inorganic phosphate
Biochemical and mechanical experiments in both skeletal (17,18) and
cardiac muscle (19,20) have demonstrated that increasing [Pi] leads to
a decrease in isometric force. Under isometric conditions, the sole force-
producing state in the model in the literature (21,22) is XBPostR, whereas
XBpreR remains as a strongly-bound state that can contribute to cross-bridge
stiffness. The binding of Pi can therefore be placed at either hbT or gappT,
because either will drive the cross-bridge cycle away from XBPostR and
decrease isometric force with increasing [Pi]. We find that placing the Pi-
binding step at gappT produces a better quantitative fit to the data (see below).
The adjustment of the original rate constant to account for [Pi] is given by
g
0
appT ¼
gappT
Pi0
; (5)
where the parameters are defined equivalently to those in Eq. 3.
pH
Changes in pH have been shown to affect the force-Ca curve in two distinct
ways: A decrease of pH leads to a decrease in the Ca2þ sensitivity as well as
a decrease in the maximum force generated at saturating levels of Ca2þ
(23,24). To incorporate these effects, we include two distinct mechanisms
of sensitivity to pH. We assume that the decrease in Ca2þ sensitivity with
decreasing pH is due to the competitive binding of Hþ to the single Ca2þ
binding site on troponin C (Fig. 1 C) (25,26), modeled as a rapid equilibrium
reaction identically for both populations of troponin with dissociation
Metabolic Regulation of Cardiac Force 269constant kdHCa and cooperativity m. This modifies the rate constant for the
binding of Ca2þ to troponin C,
k
0
onT ¼
kmdHCa þ H
0m
kmdHCa þ

Hþ
m  konT; (6)
where k0onT is the new apparent rate constant for Ca
2þ binding, konT is the
original Ca2þ binding rate constant, and H0 is the reference proton concen-
tration. The apparent rate constant for Ca2þ binding affects the transition
rates responsible for activation of the cross-bridge cycle (kpnT and knpT).
The two parameters that govern the mechanism of competitive Hþ binding,
kdHCa and m, are determined using data from the literature (see below).
The inclusion of competitive Hþ binding can account for the shift in Ca2þ
sensitivity but cannot reproduce the change in maximum tension at satu-
rating Ca2þ concentration. This effect can be incorporated by assigning
one of the (reverse) rate constants in the cross-bridge cycle (Fig. 1 A) to
be associated with the release of the metabolic Hþ (a by-product of the
ATP hydrolysis reaction; see Eq. 2). The two positions at which this reaction
could occur are hbT and gappT, as both can lead to a decrease in force with an
increase in Hþ concentration. We locate Hþ release at the reverse isomeri-
zation step, hbT, because this produces a drop in force of a magnitude that
is in better agreement with the data (see below). The adjustment of the
rate constant to account for the physiological Hþ concentration is given by
h
0
bT ¼
hbT
H0
; (7)
where the parameters are defined equivalently to those in Eq. 3. The Hþ-
dependent transition from XBPostR to XBPreR is therefore given by
h
0
bT 

Hþ

: (8)
Note that the equation for this transition rate is not yet complete, as h0bT is
also modified by MgADP (see below).
MgADP
Mechanical measurements have shown that MgADP binds to attached cross-
bridges (27–30) that remain attached after the binding event (31). Increasing
MgADPconcentrations also leads to an increase in steady-state isometric force
development in both skeletal (17,32) and cardiac (21,33) muscle preparations.
The only transition between strongly-bound states in the four-state Rice et al.
(8)modelwhere theMgADPbinding event could beplaced is fromXBpostR to
XBpreR. This, however, leads to a decrease in isometric force development
because XBpreR is a lower-force state than XBpostR. The four-state model
therefore contains an insufficient number of states to represent the binding
of MgADP. Hence, we expand state XBPostR into two force-producing
substates, AM1 and AM2, to create a five-state model (Fig. 1 B), where we
assume that the two substates contribute equally to total force and sum to
produce the same force as state XBpostR, and MgADP is assumed to bind to
state AM1. This five-state construction is equivalent to the four-state model
when binding and unbinding of MgADP is rapid (states AM1 and AM2 are
in rapid equilibrium).Wemodel theMgADPbinding stepwith a single param-
eter representing the MgADP dissociation constant, kdADP. This modifies the
rates of transitions leaving state XBPostR, i.e., g
0
xbT and h
0
bT, by
kdADP þ MgADP0
kdADP þ ½MgADP
and

kdADP þ MgADP0
MgADP0


 ½MgADP
kdADP þ ½MgADP

;
respectively, where MgADP0 is the normal physiological MgADP concen-
tration and the dissociation constant kdADP is constrained by fitting the modelto isometric force data (see below). Incorporating Eq. 4, the complete
MgATP and MgADP-dependent transition from XBPostR to PXB is given by
½MgATP  g0xbT 

kdADP þ MgADP0
kdADP þ ½MgADP

: (9)
By incorporating Eq. 8, the complete Hþ and MgADP-dependent transition
from XBPostR to XBPreR is determined as

Hþ
 h0bT 

kdADP þ MgADP0
MgADP0
 ½MgADP
kdADP þ ½MgADP

:
(10)
A full description of the model formulation and equations that have been
modified from Rice et al. (8) is given in the Appendix and the Supporting
Material, and a detailed description of all model parameters is given in the
Supporting Material.Parameter estimation and model selection
Previous studies have suggested that placement of the Pi-binding step at
either gappT or hbT provides plausible explanations for the isometric
force-Pi data (19,20,34). We found that the Extended Model best fits the
data when the Pi binding step is placed at gappT (Fig. 2 A). There is also
evidence demonstrating a decrease in stiffness with increased [Pi], which
is consistent with the binding of Pi causing the dissociation of cross-
bridge attachment (3,35). This leaves the binding location of the metabolic
Hþ along with the three new parameters, kdADP, kdHCa, and m, to be
determined.
Experiments in cardiac muscle preparations have measured an increase in
isometric force of ~10–15% when [MgADP] is increased from zero to satu-
rating concentrations in the millimolar range (21). We constrain the MgADP
dissociation constant, kdADP, to give a 13% increase in isometric force when
[MgADP] is increased from 0 to 3 mM (21). This produces a kdADP value of
4 mM, which compares well with those measured by Johnson and Adams
(36) (14 mm at 23C and 5 mm at 15C) and with Kardami et al. (37)
(8 mm at 5C) (which were obtained from bovine cardiac preparations using
independent assaying methodologies).
To determine the parameters governing the competitive binding of Hþ to
the Ca2þ binding sites on troponin C, we use the guinea pig force-Ca data of
Orchard and Kentish (24). For reasons considered in the Discussion, the
slopes of the force-Ca data are relatively flat (n ¼ 2) when compared to
the curves produced by the Rice et al. (8) model (n ¼ 7). Therefore, we
fit the relative change in Ca2þ sensitivity (Ca50) brought about by changes
in Hþ concentration. Fig. 2 B shows the result of fitting the Extended Model
to the normalized data from Orchard and Kentish (24). The Ca50 values for
the data set have been normalized to the Ca50 at pH ¼ 7. The best fit to the
data is obtained at m ¼ 1 and kdHCa ¼ 2  105 mM. For increasing values
of m, the curve becomes more concave and does not fit the data as well. The
value of 1 for the cooperativity constant,m, can be interpreted as the binding
of a single Hþ to the Ca2þ binding site and, in this model, is favored over the
binding of two or more Hþ.
Fig. 2 C shows model simulations when the metabolic Hþ is released at
either gappT or hbT (Fig. 1 B). Both simulations are qualitatively consistent
with the data inasmuch as a decrease of pH leads to a decrease in maximum
steady-state force. However, quantitatively, the placement of the Hþ release
step at hbT produces better agreement with the data from Orchard and
Kentish (24) (guinea pig trabeculae) and Godt and Nosek (21) (rabbit
papillary). Fig. 2 D shows the overall effect of pH on the force-Ca curve,
giving the expected decrease in Ca2þ sensitivity and maximum force with
decreasing pH, comparable to experimental data from Orchard and Kentish
(24) (shown in the Supporting Material—but exhibiting a much steeper
slope, because the experimental data of Orchard and Kentish (24) are
from skinned preparations).Biophysical Journal 98(2) 267–276
FIGURE 2 (A) Comparing the effect
of modeling the Pi binding step at either
gappT or hbT on the force-Pi curve. The
data points are from rabbit papillary
muscle (21). Other conditions in the
simulations: [MgATP] ¼ 5 mM,
[MgADP] ¼ 36.3 mM, pH ¼ 7.15,
[Ca2þ]i ¼ 200 mM (maximum activa-
tion), SL ¼ 2.2 mM, and T ¼ 22C. (B)
Best fit of the relative Ca2þ sensitivities
(Ca50) of the Extended Model to data
fromOrchard and Kentish (24), atm¼ 1
(kdHCa ¼ 2  105 mM) and at m ¼ 2
(kdHCa ¼ 1.8  104 mM2). The Ca50
values on the y axis are normalized to
the Ca50 at pH ¼ 7. (C) Model simula-
tion of maximum steady-state force
(under saturated Ca2þ conditions) as
a function of pH. The model simulations
correspond to the placement of the meta-
bolic Hþ release step at either gappT or
hbT in the cross-bridge cycle. The simu-
lations are normalized to force at pH 7.2
(see Fig. S1 in Supporting Material for
original data). (D) Model simulation of
steady-state force-Ca curves as a func-
tion of pH. Other conditions in the simu-
lations of panels B–D: SL ¼ 2.1 mM;
T ¼ 30C. Note that metabolite concen-
trations are set to their reference values.
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Force redevelopment and MgATP
The ExtendedModel was used to predict the effect of varying
MgATP concentration on the isometric force response and
the rate of tension redevelopment after a sudden length
change (Fig. 3 A). An increase inMgATP concentration leads
to a decrease in the normalized force, because this favors
the detachment of strongly-bound cross-bridges (g0xbT) and
thereby reduces the proportion of cross-bridges in the
strongly-bound state. The model simulations show that the
force-MgATP curve is sensitive to low levels of MgADP
concentration, because decrease of MgADP represents
a reduction in the competition for the strongly-bound state
AM1 that results in a large drop in force with increasing
MgATP. The data-set from Ebus et al. (18) lies within the
family of curves simulated by the model at low to physiolog-
ical MgADP concentrations. Fig. 3, B and C, shows the force
redevelopment after the imposition of a sudden length change,
which is assumed to detach almost all the strongly-bound
cross bridges thus reducing the developed force to zero, at
three different MgATP concentrations. Rapid detachment of
cross-bridges is simulated (at time t¼ 300 ms) by decreasing
1000-fold the forward transition rates, fappT and hfT, and
increasing 1000-fold the backward rate constants, g0appT and
h0bT, for a period of 5 ms. Fig. 3 B shows that the steady-state
force increases with decreasing MgATP concentration,
consistent with Fig. 3 A, whereas Fig. 3 C shows that theBiophysical Journal 98(2) 267–276rate of tension redevelopment decreases with decreasing
MgATP concentration. These predictions are consistent
with the results of Ebus et al. (18) (Fig. 3D), who also demon-
strated a decrease in rate of tension redevelopment with
decreasing MgATP concentrations.Sinusoidal length perturbations
Kawai et al. (3) used sinusoidal length perturbation over
a range of frequencies to determine the complex stiffness
of cardiac muscle at different MgATP and Pi concentra-
tions (in ferret myocardium). We imposed a sinusoidal
length change with an amplitude of 0.25% of L0, the
imposed sarcomere length (2.28 mm) in the Extended
Model, including both passive and active components of
tension. Fig. 4 shows the two components of complex stiff-
ness, dynamic modulus (Fig. 4 A) and phase shift (Fig. 4
B), as a function of perturbation frequency at different Pi
concentrations, compared with the experimental data from
Kawai et al. (3). (Similar plots showing the comparison
between model and data for dynamic modulus and phase
shift at different MgATP concentrations can be found in
the accompanying Supporting Material, and provide further
validation of the dependence of cross-bridge cycling on
MgATP.)
Our simulations reproduce, qualitatively and semiquantita-
tively, features observed in the experimental data. Both
demonstrate that with increasing frequency the dynamic
FIGURE 3 (A) Model simulations of
isometric force as a function of MgATP
concentration at different MgADP
concentrations. The data points are
from rat ventricular tissue (18) for which
MgADP concentration is not specified
and therefore assumed to be low/zero.
The simulated curves are normalized to
the maximum force from the data. Other
conditions in the simulation: [Pi] ¼
0 mM, pH ¼ 7, [Ca2þ] ¼ 200 mM,
SL¼ 2.1 mM, and T¼ 20C. (B) Model
simulations of the time course of
isometric force recovery after a sudden
length change as a function of MgATP
concentration. The change in length is
applied at 300 ms (see text for details).
The curves are normalized to the maxi-
mum force at [MgATP] ¼ 0.1 mM.
Other conditions are: [MgADP] ¼
1 mM, [Pi] ¼ 2 mM, pH ¼ 7, [Ca2þ] ¼
200 mM, SL ¼ 2.1 mM, and T ¼ 20C.
(C) Same simulation as panel B, except
that each curve has been normalized
to its own maximum force so that the
rate of force redevelopment at different
MgATP concentrations can be com-
pared to data shown in panel D. (D)
Experimental data reproduced with per-
mission from Fig. 5 A of Ebus et al. (18).
Metabolic Regulation of Cardiac Force 271modulus increases, whereas the phase shift increases toward
a peak before decreasing. Dynamic modulus is a measure of
muscle stiffness, which is directly proportional to force and
is therefore a function of the fraction of cross-bridges inthe strongly-bound state and their mean distortions. In the
model, stiffness increases with frequency because the average
distortion of the strongly-bound cross-bridges increases
before they can detach.FIGURE 4 Two measures of com-
plex stiffness: dynamic modulus (A)
and phase shift (B), calculated for the
model as a function of perturbation
frequency and [Pi]. (C and D) Experi-
mental data from ferret cardiac muscle
(reproduced with permission from
Wolters Kluwer Health, from Kawai
et al. (3)). Dynamic modulus is calcu-
lated as the amplitude of the normalized
force oscillation in response to a sinu-
soidal length change protocol with an
amplitude of 0.25% L0 (where L0 is set
at 2.28 mm). Other conditions in the
simulations: [MgATP] ¼ 5 mM,
pH ¼ 7.15, [Ca2þ] ¼ 200 mM, and
T¼ 20C. We also assume [MgADP]¼
0, as there was no mention of its presence
in the experimental protocol described
by Kawai et al. (3).
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272 Tran et al.The response to a change in [Pi] (and in [MgATP]; see
Supporting Material) is very similar to the experimental
observations. Stiffness decreases with increasing [Pi]
(Fig. 4 A), whereas the peaks of the phase shifts move to a
lower frequency. Increasing [Pi] (or [MgATP]) leads to
a decrease in stiffness at a given stimulation frequency
because it favors detachment of cross-bridges (reducing the
proportion in the strongly-bound state, and hence, stiffness).
An increase in [Pi] favors detachment of cross-bridges (from
XBPreR) in the anti-clockwise direction, whereas an increase
in [MgATP] favors detachment (from XBPostR) in the clock-
wise direction.Force development during ischemia: sensitivity
analysis
A key motivation for our study was to investigate the effects
of changingmetabolite concentrations during ischemia on the
development of active force. Befroy et al. (38) measured
[PCr], [ATP], and pH, and developed pressure, during 20 minFIGURE 5 Production of force during ischemia. Imposed ischemic time course
time courses for the change in (A) [MgATP], (B) [Pi], (C) [MgADP], and (D) pH
Befroy et al. (38) and Terkildsen et al. (10). These time courses are then used to sim
sensitivity of maximal force to [MgATP], [Pi], [MgADP], pH, and [Ca2þ] at four
ized force. Each column illustrates a particular time point after the onset of ischem
time point. (Curves) Effect on force (sensitivity) of changing values of [MgATP],
For plots A–D, [Ca2þ] is held at 200 mM to achieve maximum force. Other con
Biophysical Journal 98(2) 267–276of zero-flow global ischemia in perfused guinea pig hearts.
These data were used by Terkildsen et al. (10) to calculate
the time courses for [ADP] (using the creatine kinase
equilibrium constant) and [Pi] (assuming conservation of
the total phosphate pool). These time courses are shown
in the first column of Fig. 5 (rows A–D), with the correspond-
ing isometric force at maximum Ca2þ activation ([Ca2þ] ¼
200 mM; row E) calculated from the model. The simulation
shows force decreasing rapidly to ~10% of its preischemic
value after ~10 min, consistent with the pressure measure-
ments from Befroy et al. (38) and Allen and Orchard (1).
To investigate the relative effects of the metabolites and
pH on the maximum force during ischemia, we performed
a sensitivity analysis at times T ¼ 0 (normoxic conditions),
and T ¼ 2.5, 5, and 10 min after the onset of ischemia.
Each curve shows the change in maximum force (y axis)
as one metabolite is varied (x axis), whereas the others are
held at their respective values for that time point (shown as
solid circles on the sensitivity curves). For example, row B
shows the negative inotropic effect of increasing [Pi] ons for metabolites, pH, and simulated force are shown in the first column. The
are redrawn at five distinct time points (T ¼ 0, 2.5, 5, 10, and 15 min) from
ulate the isometric force response (row E). The other four columns show the
different time points during ischemia. The y axis of each plot shows normal-
ia. (Solid circles) Force and respective metabolite, pH, or Ca2þ level at that
[Pi], [MgADP], pH, or [Ca2þ] (rows A–E), while keeping the others constant.
ditions in the simulations: SL ¼ 2.2 mM and T ¼ 25C.
Metabolic Regulation of Cardiac Force 273force when [MgATP], [Pi], and pH are kept constant,
whereas row C shows an initially positive effect of [MgADP]
on force, with a small but negative effect on force after a few
minutes of ischemia. Row E shows the effect of calcium on
force at each time point post-onset of ischemia, showing that
the calcium level required to achieve the diminishing
maximal force also increases during the progression of
ischemia.
These results indicate that the maximum force is most
sensitive to changes in [Pi] and pH (the curves for [Pi] and
pH have steepest gradient over the physiological range).
The initial rapid decrease in maximum force after the onset
of ischemia is primarily caused by increasing [Pi] and
decreasing pH. We note, however, that these effects are
not additive due to the nonlinear dependencies among vari-
ables in the model. Force is not strongly sensitive to MgATP
or MgADP. At T ¼ 0, increasing [MgATP] leads to
a decrease in force, whereas after T ¼ 2.5 min, force
becomes insensitive to [MgATP]. For [MgADP], at T ¼
0 force increases with increasing [MgADP], becoming
almost insensitive at T ¼ 2.5 min, and starts to decrease after
T ¼ 5 min. These changes in the sensitivity to [MgATP] and
[MgADP] over the time course of ischemia are due to the
changing [Pi] and pH levels. The switch from increasing to
decreasing sensitivity to [MgADP] is a consequence of the
MgADP-binding step occurring between two strongly-
bound states. The shift to the right (higher Ca) in the
force-Ca curve (Row E) demonstrates the reduction of sensi-
tivity to Ca2þ during ischemia. This is brought about
primarily by the increased inhibition of Ca2þ binding to
troponin C, due to falling pH (Fig. 2 D).DISCUSSION
The position of theMgATP andMgADP binding steps within
the cross-bridge cycle are well constrained by data from the
literature. MgATP was assumed to bind at gxbT because this
transition detaches a strongly-bound cross-bridge, consistent
with experimental observations (7,18). Experimental obser-
vations have also shown that the cross-bridge head remains
strongly attached after the MgADP binding event, and that
increasing [MgADP] leads to an increase in isometric force
(21,31,33), which leads us to introduce a new state into the
original cross-bridge scheme from Rice et al. (8). The binding
positions for Pi and themetabolicHþ in the cross-bridge cycle
are not as well characterized in the literature. Data indicate
that an increase in the concentrations of either Pi or Hþ will
lead to a decrease in isometric force (21–24). This qualitative
behavior can be satisfied by placing either of these binding
events at gappT or hbT (Fig. 1), and we have determined
a scheme that gives the best fit to experimental data (Fig. 2,
A and C). Pi binding at gappt is further supported by the sinu-
soidal length perturbation simulations in Fig. 4 that reproduce
the qualitative, and many of the quantitative, aspects of the
experimental data. (MgATP binding is also further supportedby these simulations—see Supporting Material.) These simu-
lations demonstrate the recruitment and distortional stiff-
nesses identified by Campbell et al. (39), who analytically
derived the frequency response of the Razumova et al. (40)
model—a precursor to the Rice et al. (8) model. The distor-
tional stiffness rises with increasing frequency because the
cross-bridges are stretched further before they can detach,
whereas the recruitment stiffness is a function of the fractional
occupancies of the strongly-bound cross-bridge states (XBPreR
and XBPostR). Increasing either [MgATP] or [Pi] leads to
a decrease in the fractional occupancy of these strongly-
bound states, resulting in a decrease in stiffness, as is observed
in the experimental data of Kawai et al. (3).
Decreasing pH, as occurs during ischemia, has been shown
to affect the force-Ca curves in two distinct ways, shifting the
force-Ca curve to the right (reducing Ca2þ sensitivity) (23–
26,41), and decreasing the maximum force at saturating
Ca2þ (23,24). We have shown that competitive binding of
Hþ for the Ca2þ-binding site on troponin C can account for
the pH-dependent shift in Ca50 and that the release of the
ATP hydrolysis-derived proton directly affects kinetics of
the cross-bridge cycle, leading to a decrease inmaximumforce
with decreasing pH. Together, these mechanisms can repro-
duce the experimentally observed steady-state pH-dependent
force-Ca curves (Fig. 2D). This is consistent with the study by
Crampin and Smith (9), who also used two distinct mecha-
nisms to capture the pH-dependent force-Ca data, but did so
by using a phenomenological model for force generation.
Our model also suggests that only one Hþ binds to the Ca2þ
binding site and that the release of the metabolic Hþ occurs
during the power-stroke and after the release of Pi.Model limitations
This model of Ca2þ activation and cross-bridge kinetics is
a mean-field representation of cooperative spatial interac-
tions between regulatory proteins and cross-bridge action.
Rather than explicitly describing these spatial interactions,
which would require computationally intensive PDEs, the
model achieves this by using a mean value to represent the
population as a whole and, in doing so, can be described
using a set of ordinary differential equations. The gains, in
terms of computational efficiency, of this approach are
offset by the limitations imposed on modeling the feedback
behavior. Rice et al. (42) have shown that mean-field models
generate hysteresis artifacts not seen in real muscle when
global feedback on Ca2þ-binding affinity is incorporated,
i.e., allowing strongly-bound cross-bridges to influence
explicitly the affinity of Ca2þ binding. Nevertheless, feed-
back mechanisms onto the Ca2þ affinity for troponin C are
necessary for simulating observed phenomena such as
ADP-contraction (33,43,44) and spontaneous oscillatory
contractions (45,46). These phenomena have been success-
fully simulated using models with different feedback mech-
anisms, although it must be pointed out that these models areBiophysical Journal 98(2) 267–276
274 Tran et al.designed to study these specific phenomena only and cannot
simulate other behavior such as force-Ca relations (33,46).Inversion of the force-MgADP relationship
One of the unexpected outcomes from this modeling study is
the dependence of the force-MgADP relationship on the
other metabolites: MgATP, Pi, and Hþ. Fig. 3 A shows a
reversal point at [MgATP] ¼ 0.9 mM where the MgADP-
dependent curves intersect. At this point, isometric force is
insensitive to the MgADP concentration. For [MgATP] <
0.9 mM, an increase in MgADP concentration leads to
a decrease in force, whereas for [MgATP] > 0.9 mM,
increasing MgADP increases force. Varying [MgADP] and
[Pi] will shift the position of this reversal point. This effect
is not limited to MgATP, because the trend of the force-
MgADP curve also depends on [Hþ] and all the other param-
eters in the cross-bridge cycle. This reversal behavior is
unique to the MgADP binding step, as the sensitivity of force
to [MgATP], [Pi], and [Hþ] will exhibit only a unidirectional
response. This emergent feature of the model appears consis-
tent with data showing a biphasic force-MgADP curve that
initially increases with increasing MgADP before inverting
and decreasing as MgADP is further increased (Fig. 5 from
Shimizu et al. (43)). Our model is able to reproduce this
biphasic behavior qualitatively if we assume that [Pi] is
increasing commensurate with [MgADP] (see Fig. S2 in
Supporting Material). The increasing [Pi] tilts the balance
of XBPostR toward AM2 such that further increases in
[MgADP] will increase the fraction of cross-bridges in state
XBPreR (which is a non-force-generating state under
isometric conditions). The mechanism underlying this
behavior is centered around the placement of the MgADP
binding step between the two strongly-bound substates that
make up XBPostR (AM1 and AM2). The direction of the
force-MgADP relationship depends on the balance between
the competition for these two states. An analysis of this
reversal point and the conditions under which it occurs is
provided in the Supporting Material.Reversibility
In our model of the cross-bridge cycle, the value of fxbT is
calculated to be minute. The small magnitude of this reverse
rate constant restricts the cross-bridge from cycling back-
ward to any appreciable extent. Despite this, it is obligatory
to include fxbT to ensure that the cycle is thermodynamically
consistent. Simulation of muscle stretch under conditions
where the free energy was artificially set to be positive
produced a very small reversal flux. This is consistent with
many studies in the literature that have attempted, but failed,
to generate ATP through the application of external work
(47–50). Our model shows that the cross-bridge cycle can
reverse, albeit at a very low rate, and this is primarily due
to the kinetics of the cross-bridge cycle.Biophysical Journal 98(2) 267–276Implications for ischemia
Our simulation of ischemia shows an exponential-like
decrease in force that falls to ~10% after 10 min of ischemia
(Fig. 5). These results are consistent with the experimental
data of Befroy et al. (38) from perfused guinea pig hearts.
We have isolated the effects of the metabolic changes on
the cross-bridge cycle from effects of changing Ca2þ levels
by setting a high [Ca2þ]. By considering each of the metabo-
lite time courses separately, the sensitivity analysis suggests
that [Pi] and pH are the primary contributors to the rapid
fall in maximum tension during ischemia (Fig. 5). However,
the metabolic changes that occur during ischemia also have
direct effects on SERCA and the Na-pump, whereas falling
pH directly inhibits the ryanodine receptors and indirectly
leads to a rise in intracellular [Naþ] (see (9) and references
therein). Inhibition of SERCA and elevation of intracellular
[Naþ] will contribute to a rise in the diastolic Ca2þ concentra-
tion and the amplitude of the Ca2þ transient although the force
production decreases. Row E of Fig. 5 shows that an increase
in [Ca2þ] cannot restore the loss of contractile strength
brought about by the rise in [Pi] and fall in pH. Furthermore,
the fall in pH greatly reduces the sensitivity of the force-Ca
response, pushing the Ca50 past 10 mM after 10 min of
ischemia.
The model developed here incorporates metabolite depen-
dence into a model of cooperative activation and cross-
bridge kinetics, which can reproduce a range of important
metabolite/force/length/Ca2þ characteristics. The model is
constructed using ordinary differential equations, making it
ideal for integrating into whole-cell models of excitation-
contraction. The simulations of ischemia in this study were
carried out by imposing the time course of metabolic changes
onto our model. The next step is to integrate this cross-bridge
model into a cellular framework and to couple it to a model
of mitochondrial oxidative phosphorylation, such that the
metabolic time courses are driven by the mitochondria
which, in turn, drive the cross-bridge model. Along with
published models of the cardiac Na-pump (2,10) and
SERCA (11), this metabolite-sensitive model of the cross-
bridge cycle provides a platform on which to develop
a whole-cell model of cardiac electrophysiology and Ca2þ
dynamics that is capable of simulating the effects of compro-
mised energetics during ischemia.
The model is available in the CellML repository at http://
models.cellml.org/workspace/tran_2009. A MATLAB (The
MathWorks, Natick, MA) version of the code is also avail-
able from the authors. Full details and further analysis of
the model are available in the Supporting Material.APPENDIX
All parameters in the Extended Model are as given in Rice et al. (8), except
xbmodspecies ¼ 0.2, as described above. Three new parameters are intro-
duced: kdHCa ¼ 2  105 mM, m ¼ 1, and kdADP ¼ 4 mM.
Metabolic Regulation of Cardiac Force 275The following ordinary differential equations describing the cross-bridge
kinetics are modified from Eqs. 14–17 from Rice et al. (8):
d
dt
PXB ¼ knpT  NXB þ aþ3  XBPostR þ a1
 XBPreR 

kpnT þ aþ1 þ a3
  PXB
d
dt
XBPreR ¼ aþ1 PXB þ a2  XBPostR

a1 þ aþ2
 XBPreR
d
dt
XBPostR ¼ a3  PXB þ aþ2  XBPreR
a2 þ aþ3   XBPostR
NXB ¼ 1 ðPXB þ XBPreR þ XBPostRÞ:
where the values a1
þ ¼ fappT, a2þ ¼ hfT, a1–¼ [Pi] g0appT, a3–¼ fxbT, and
a2
–, a3
þ are defined by Eqs. 9 and 10, respectively. The values fappT and hfT,
are rate constants from Rice et al. (8) and g0xbT, g0appT, and h0bT are defined in
Eqs. 3, 5, and 7, respectively. The fxbT is calculated using the constraint from
Eq. 1,
fxbT ¼ kdADP  fappT  hfT  g
0
xbT
g
0
appT  h0bT  kMgATP
; (11)
where kMgATP¼ 15,400 mM2 is the equilibrium constant for the ATP hydro-
lysis reaction and is defined as
kMgATP ¼ eDG0=RT :
DG0 ¼ 10.3 KJ mol1 is the standard free energy change, taking into
account [Hþ] in the hydrolysis reaction (Eq. 2), R is the universal gas
constant, and T ¼ 298 K.
The differential equations governing the rate of change of the mean distor-
tions, Eqs. 29 and 30 of Rice et al. (8), are also modified:
d
dt
xXBPreR ¼ 1
2
dSL
dt
þ f
XBDutyFractPreR
 aþ1  xXBPreR
þ a2  ðxXBPostR  x0  xXBPreRÞ

d
dt
xXBPostR ¼ 1
2
dSL
dt
þ f
XBDutyFractPostR

aþ2 ðxXBPreR
þ x0  xXBPostRÞ

:
Addition of fxbT modifies Eqs. 31 and 32 of Rice et al. (8), used to calculate
the steady-state occupancies of XBPreR and XBPostR:
XBDutyFractPreR ¼
a3 a

2 þ aþ3 aþ1 þ a2 aþ1
SDutyFractXB
XBDutyFractPostR ¼
aþ1 a
þ
2 þ a3 a1 þ a3 aþ2
SDutyFractXB
SDutyFractXB ¼ aþ1 aþ2 þ a3 a1 þ a3 aþ2 þ a3 a2 þ aþ3 aþ1
þ a2 aþ1 þ aþ2 aþ3 þ a3 a1 þ aþ3 a1 :
Equations 33 and 34 in Rice et al. (8), used to normalize the force output,
become
XBMaxPreR ¼
fxbhb þ gxbfapp þ hbTfapp
SMaxXB
XBMaxPostR ¼
fapphf þ fxbgapp þ fxbhb
SMaxXB
SMaxXB ¼ hfgxb þ hbgapp þ gxbgapp þ fxbhb þ gxbfapp
þ hbfapp þ fxbgapp þ fapphf þ fxbhb:In the Extended Model, the normalizing force is therefore determined by the
force at the reference physiological metabolite levels under optimal condi-
tions (see (8) for details). The value fxb is defined similarly to Eq.11, except
that the base value of the rate constant is used, i.e., fapp instead of fappT.SUPPORTING MATERIAL
An analysis of the force-ADP relationship of the model and a list of the
model parameters and their sources are available at http://www.biophysj.
org/biophysj/supplemental/S0006-3495(09)01617-8.
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